Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2011 3
2012 8
2013 12
2014 22
2015 40
2016 105
2017 168
2018 209
2019 354
2020 389
2021 391
2022 391
2023 480
2024 159

Text availability

Article attribute

Article type

Publication date

Search Results

2,348 results

Results by year

Filters applied: . Clear all
Page 1
Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, Goodlin SJ, Maurer MS, Alexander KP, Rich MW, Tjia J; Geriatric Cardiology Section Leadership Council, American College of Cardiology. Krishnaswami A, et al. J Am Coll Cardiol. 2019 May 28;73(20):2584-2595. doi: 10.1016/j.jacc.2019.03.467. J Am Coll Cardiol. 2019. PMID: 31118153 Free PMC article. Review.
Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medications with goals of care when life expectancy is reduced. Using a framework to deprescribe, this review addresses the rationale, evidenc …
Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medicatio …
Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis.
Zhou D, Chen Z, Tian F. Zhou D, et al. J Am Med Dir Assoc. 2023 Nov;24(11):1718-1725. doi: 10.1016/j.jamda.2023.07.016. Epub 2023 Aug 12. J Am Med Dir Assoc. 2023. PMID: 37582482 Review.
OBJECTIVES: Deprescribing reduces polypharmacy in older adults. A thorough study of the effect of deprescribing interventions on clinical outcomes in older adults is presently lacking. As a result, we evaluated the impact of deprescribing on clinical outcomes …
OBJECTIVES: Deprescribing reduces polypharmacy in older adults. A thorough study of the effect of deprescribing interventions …
Rational deprescribing in the elderly.
Williams S, Miller G, Khoury R, Grossberg GT. Williams S, et al. Ann Clin Psychiatry. 2019 May;31(2):144-152. Ann Clin Psychiatry. 2019. PMID: 31046036 Review.
Despite this, elderly patients are currently being prescribed a median of 7 medications, which often causes more harm than benefit, and emphasizes the importance of deprescribing. METHODS: Five classes of potentially inappropriate medications for the elderly population, es …
Despite this, elderly patients are currently being prescribed a median of 7 medications, which often causes more harm than benefit, and emph …
Perspectives on deprescribing in palliative care.
Tjia J, Karakida M, Alcusky M, Furuno JP. Tjia J, et al. Expert Rev Clin Pharmacol. 2023 May;16(5):411-421. doi: 10.1080/17512433.2023.2197592. Epub 2023 Apr 19. Expert Rev Clin Pharmacol. 2023. PMID: 36995162 Review.
INTRODUCTION: Pharmacotherapy plays a critical role in the delivery of high-quality palliative care, but the intersection of palliative care and deprescribing has received little attention. AREAS COVERED: We conducted a scoping review of English language articles using Pub …
INTRODUCTION: Pharmacotherapy plays a critical role in the delivery of high-quality palliative care, but the intersection of palliative care …
[Deprescribing in Danish clinical treatment guidelines].
Lundby C, Burghle A, Ryg J, Abuna L, Alnabhan WA, Thanikaikumaran JK, Esmael A, Søndergaard J, Pottegård A. Lundby C, et al. Ugeskr Laeger. 2022 Jul 4;184(27):V01220063. Ugeskr Laeger. 2022. PMID: 35786494 Free article. Review. Danish.
For dementia, type 2 diabetes, and osteoporosis, guidance was primarily focused on when to consider and implement deprescribing, with limited practical guidance on how to deprescribe. No guidance for deprescribing antihypertensives was identified. This highli …
For dementia, type 2 diabetes, and osteoporosis, guidance was primarily focused on when to consider and implement deprescribing, with …
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, Lasserson D, Krska J, Mangin D, Byng R, Wallace E, Ranson E. Reeve J, et al. Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475. Health Technol Assess. 2022. PMID: 35894932 Free PMC article. Review.
The TAILOR medication synthesis sought to help understand how best to support deprescribing in older people living with multimorbidity and polypharmacy. ...Our first (scoping) review produced a map of what we know about deprescribing: how it is done and if it is saf …
The TAILOR medication synthesis sought to help understand how best to support deprescribing in older people living with multimorbidit …
Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2.
Curtin D, Gallagher P, O'Mahony D. Curtin D, et al. Age Ageing. 2021 Feb 26;50(2):465-471. doi: 10.1093/ageing/afaa159. Age Ageing. 2021. PMID: 32997135
RESULTS: STOPPFrail version 2 emphasises the importance of shared decision-making in the deprescribing process. A new method for identifying older people who are likely to be approaching end-of-life is included along with 25 deprescribing criteria. Guidance relating …
RESULTS: STOPPFrail version 2 emphasises the importance of shared decision-making in the deprescribing process. A new method for iden …
[Deprescribing: an essential part of rational pharmacotherapy].
Engi Z, Matuz M, Soós G, Hajnal F, Szökő É, Viola R, Csupor D, Benkő R. Engi Z, et al. Orv Hetil. 2023 Jun 18;164(24):931-941. doi: 10.1556/650.2023.32782. Print 2023 Jun 18. Orv Hetil. 2023. PMID: 37330979 Review. Hungarian.
Deprescribing is a planned, systematic process supervised by a healthcare professional. ...In our article, based on the international literature, we review potential deprescribing targets such as the characteristics of high-risk patients, medications that should pro
Deprescribing is a planned, systematic process supervised by a healthcare professional. ...In our article, based on the international
Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients.
Chaput G, Bhanabhai H. Chaput G, et al. Curr Oncol. 2023 Nov 2;30(11):9701-9709. doi: 10.3390/curroncol30110704. Curr Oncol. 2023. PMID: 37999124 Free PMC article. Review.
Improved patient quality of life, risk reduction of side effects or worse clinical outcomes, and a decrease in healthcare costs are well-documented benefits of deprescribing. Deprescribing and advance care planning both require consideration of patients' values, pre …
Improved patient quality of life, risk reduction of side effects or worse clinical outcomes, and a decrease in healthcare costs are well-doc …
Deprescribing in cardiometabolic conditions in older patients: a systematic review.
Hickman E, Seawoodharry M, Gillies C, Khunti K, Seidu S. Hickman E, et al. Geroscience. 2023 Dec;45(6):3491-3512. doi: 10.1007/s11357-023-00852-z. Epub 2023 Jul 5. Geroscience. 2023. PMID: 37402905 Free PMC article. Review.
We conduct a systematic review to investigate current deprescribing practices and evaluate outcomes and adverse events with deprescribing of preventive medications in older patients with either an end-of-life designation or residing in long-term care facilities with …
We conduct a systematic review to investigate current deprescribing practices and evaluate outcomes and adverse events with depres
2,348 results